ATG5 and cranioectodermal dysplasia: Therefore, significant reduction in percentage of CD11b, IL‐6, TUNEL, or APG5L/ATG cells, which are in particular seen after 20 weeks of CED, seem to be responsible for the inhibition of atherosclerosis progression after 20 weeks of CED.